Recovery of Vision in Myelin Oligodendrocyte Glycoprotein-IgG Optic Neuritis Without Treatment: A Case Series

J Neuroophthalmol. 2023 Dec 1;43(4):e126-e128. doi: 10.1097/WNO.0000000000001583. Epub 2022 Jun 24.

Authors

Amir R Vosoughi¹, Alexandra Muccilli, Raphael Schneider, Dalia Rotstein, Jonathan A Micieli

Affiliation

¹ Max Rady College of Medicine (ARV), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Division of Neurology, Department of Medicine (AM, RS, DR), St. Michael's Hospital, Unity Health, University of Toronto, Toronto, Ontario, Canada; Department of Ophthalmology and Vision Sciences (JAM), University of Toronto, Toronto, Ontario, Canada; and Kensington Vision and Research Centre (JAM), Toronto, Ontario, Canada.

PMID: 36166801
DOI: 10.1097/WNO.0000000000001583

No abstract available

MeSH terms

Aquaporin 4
Autoantibodies
Humans
Immunoglobulin G
Myelin-Oligodendrocyte Glycoprotein
Optic Neuritis* / diagnosis
Optic Neuritis* / drug therapy

Substances

Myelin-Oligodendrocyte Glycoprotein
Autoantibodies
Immunoglobulin G
Aquaporin 4